STAT3 and breast carcinoma: We found that pretreatment with FLLL32 but not curcumin (20 μM) was able to inhibit the induction of STAT3 phosphorylation by IL-6 in MDA-MB-453 breast cancer cells, and the effect of FLLL32 was more potent than curcumin (Figure 4A, B).